We are live on ! Find out more
ARCT icon

Arcturus Therapeutics
ARCT

135 hedge funds and large institutions have $865M invested in Arcturus Therapeutics in 2020 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 54 increasing their positions, 33 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 33

28% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 32

26% more call options, than puts

Call options by funds: $46.9M | Put options by funds: $37.1M

10% more capital invested

Capital invested by funds: $783M → $865M (+$81.7M)

6% more funds holding

Funds holding: 127 → 135 (+8)

2.24% more ownership

Funds ownership: 74.68% → 76.92% (+2.2%)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
135
Holders Change
+8
Holders Change %
+6.3%
% of All Funds
2.39%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
41
Increased
54
Reduced
33
Closed
32
Calls
$46.9M
Puts
$37.1M
Net Calls
+$9.71M
Net Calls Change
-$859K

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$141M
2
AIM
ARK Investment Management
Florida
+$99.1M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$48.7M
4
O
OrbiMed
New York
+$44.8M
5
BlackRock
BlackRock
New York
+$42M

Top Sellers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
-$68.4M
2
State Street
State Street
Massachusetts
-$37.1M
3
CAM
Cormorant Asset Management
Massachusetts
-$30M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$20.7M
5
EARNEST Partners
EARNEST Partners
Georgia
-$20.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$3.52M +$1.25M +18,424 +29%
RA
27
Royce & Associates
New York
$3.46M – – –
TC
28
TownSquare Capital
Utah
$3.38M +$5.27M +77,816 New
Barclays
29
Barclays
United Kingdom
$3.29M +$4.55M +67,142 +775%
CS
30
Candriam SCA
Luxembourg
$2.33M -$1.77M -26,087 -33%
CCPM
31
Cooper Creek Partners Management
New York
$2.19M – – –
Voloridge Investment Management
32
Voloridge Investment Management
Florida
$2.18M +$3.4M +50,151 New
CS
33
Credit Suisse
Switzerland
$2.15M -$1.76M -26,030 -34%
SEC
34
Seven Eight Capital
New York
$2.03M +$3.17M +46,819 New
PIM
35
Platinum Investment Management
Australia
$1.92M +$3M +44,333 New
Creative Planning
36
Creative Planning
Kansas
$1.92M -$2.03K -30 -0.1%
Swiss National Bank
37
Swiss National Bank
Switzerland
$1.91M +$54.2K +800 +2%
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$1.86M +$423K +6,249 +17%
Morgan Stanley
39
Morgan Stanley
New York
$1.76M +$492K +7,269 +22%
Citadel Advisors
40
Citadel Advisors
Florida
$1.66M -$18.4M -271,999 -88%
TD Asset Management
41
TD Asset Management
Ontario, Canada
$1.63M +$1.33M +19,597 +109%
SSA
42
Schonfeld Strategic Advisors
New York
$1.53M -$8.74M -129,102 -79%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$1.44M +$611K +9,016 +37%
Citigroup
44
Citigroup
New York
$1.43M +$2.08M +30,641 +1,322%
First Trust Advisors
45
First Trust Advisors
Illinois
$1.41M +$2.2M +32,412 New
Millennium Management
46
Millennium Management
New York
$1.34M +$2.09M +30,865 New
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$1.32M +$650K +9,600 +46%
AllianceBernstein
48
AllianceBernstein
Tennessee
$1.31M +$948K +14,000 +87%
SCA
49
Snowden Capital Advisors
New York
$1.3M +$1.2M +17,789 +146%
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
$1.25M +$221K +3,261 +22%
1
2
3 4 5

ARCT Hedge Fund Activity: Q4 2020 in Review

135 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q4 2020, worth a combined $865M — up 10% from $783M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new ARCT positions and 32 closed out — a net gain of 9 holders — while 54 added to existing stakes and 33 trimmed.

The largest buyer was Federated Hermes, adding an estimated $141M. The largest seller was HealthCor Management, exiting entirely with an estimated $68.4M sold.

  • 135 institutional investors held Arcturus Therapeutics (ARCT) as of Q4 2020, up from 127 in Q3 2020.
  • Funds reported $865M of Arcturus Therapeutics stock for Q4 2020, up 10% quarter-over-quarter.
  • 41 funds opened new Arcturus Therapeutics positions in Q4 2020 and 32 closed out, a net change of +9 holders.
  • The largest Arcturus Therapeutics buyer in Q4 2020 was Federated Hermes, an estimated $141M added.
  • The largest Arcturus Therapeutics seller in Q4 2020 was HealthCor Management, an estimated $68.4M sold.

Based on aggregated 13F filings for Q4 2020.